Pharmacogenomic Testing and Patient Perception Inform Pain Pharmacotherapy
(1) Background: Chronic pain is one of the most common reasons for individuals to seek medications. Historically, opioids have been the mainstay of chronic pain management. However, in some patient populations, opioids fail to demonstrate therapeutic efficacy, whereas in other populations, opioids m...
Main Authors: | Feng-Hua Loh, Brigitte Azzi, Alexander Weingarten, Zvi G. Loewy |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/11/1112 |
Similar Items
-
Update on the pharmacogenomics of pain management
by: Kaye AD, et al.
Published: (2019-07-01) -
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
by: Catarina Correia, et al.
Published: (2022-08-01) -
Pharmacogenomics of neuropathic pain
by: Vandana Sharma
Published: (2017-01-01) -
Cannabis Pharmacogenomics: A Path to Personalized Medicine
by: Mariana Babayeva, et al.
Published: (2023-04-01) -
Pharmacogenomic testing: aiding in the management of psychotropic therapy for adolescents with autism spectrum disorders
by: Bose-Brill S, et al.
Published: (2017-09-01)